Barry Canton
Founder @ Ginkgo Bioworks
Boston, United States
Barry Canton is a startup investor at Ginkgo Bioworks in Boston. Barry Canton is the Founder of Ginkgo Bioworks.
Last updated:
For AI agents: llms.txt
About Ginkgo Bioworks
Ginkgo Bioworks is a biotechnology firm. It is a developer of biological engineering products and custom microbes across multiple markets. It designs, engineer, develops, tests, and licenses organisms. It discovers molecules in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. It also provides probiotic bacteria toprotect the body from dangerous infections, and it generates libraries of molecules. It serves cultured ingredients, carbon mitigation, probiotics, and natural product discovery markets.
Ginkgo Bioworks Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Anna Marie Wagner
SVP, Corporate Development
|
|||
|
Barry Canton
Founder
|
|||
Behzad Mahdavi
Senior Vice President Biopharma Manufacturing & Life Sciences Tools
|
|||
Daniel Robinson
Platform Strategy & Development
|
|||
Han Xu
Senior Product Designer
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
